A study to find out whether a PET-CT scan can help to tell who needs to have rituximab or obinutuzumab after the initial treatment for lymphoma (PETReA)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 3

Details

This study is for people with follicular lymphoma. Everyone taking part is going to have treatment that reaches their whole body (systemic treatment) for the first time.

Cancer Research UK supports this trial.

Recruitment start: 10 May 2018

Recruitment end: 31 October 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Andrew Pettitt

Supported by

Cancer Research UK

National Cancer Research Institute (NCRI)

University of Liverpool

Other information

This is Cancer Research UK trial number CRUK/16/017.

Last reviewed: 31 Oct 2025

CRUK internal database number: 15119

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.